Clinical Trial Update: Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops [Phase 4]

View source ↗

Summary

A phase 4 trial evaluating 0.03% tacrolimus eye drops for dry eye symptoms in Sjogren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Sjogren Syndrome

Drugs mentioned

• Tacrolimus Eye Drops 0.03% (Tacrolimus)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Sjogren Syndrome, Dry Eye Syndrome | Phase 4 | Status: COMPLETED